MYMAN got into Peregrine Pharmaceuticals (PPHM) last year. There's been no big payoff yet but I'm stickin' with PPHM. They reported positive news this week on their drug bavituximab (see below) But the company may do a reverse split within a month to remain trading on Nasdaq.Currently trading at 0.68
October 5, 2009: Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
No comments:
Post a Comment